Spontaneous bacterial peritonitis due to carbapenemase-producing Enterobacteriaceae: Etiology and antibiotic...

Area of Science:

• Infectious Diseases
• Microbiology
• Pharmacology

Background:

• Carbapenem antibiotics, introduced in the 1980s, are crucial for treating multidrug-resistant gram-negative bacteria.
• Carbapenem-resistant Enterobacteriaceae (CRE) have emerged as a significant cause of spontaneous bacterial peritonitis (SBP) in the last decade.
• CRE-associated SBP infections exhibit higher mortality rates compared to infections with carbapenem-susceptible bacteria.

Purpose of the Study:

• To review the molecular characteristics of CRE causing SBP.
• To summarize the epidemiology of CRE-associated SBP.
• To discuss potential treatment strategies for SBP caused by CRE.

Main Methods:

• Literature review of studies on carbapenem-resistant Enterobacteriaceae (CRE) and spontaneous bacterial peritonitis (SBP).
• Analysis of molecular features, epidemiological data, and treatment outcomes reported in existing research.
• Synthesis of current knowledge regarding CRE in the context of SBP management.

Main Results:

• CRE are increasingly identified as causative agents of SBP.
• Infections with CRE demonstrate a poorer prognosis and higher mortality.
• Existing antibiotic guidelines for SBP may be inadequate for CRE cases, with limited recognition of rapid de-escalation strategies.

Conclusions:

• CRE represent a growing threat in spontaneous bacterial peritonitis, necessitating updated treatment approaches.
• Further research and guideline revisions are required to address the challenges posed by CRE in SBP management.
• Understanding CRE's molecular and epidemiological profile is key to developing effective therapeutic interventions.